SCHEMBL66617

SCHEMBL66617

c1ncc2nn[nH]c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29993678 1.00
SCHEMBL31729486 0.73 KDM4A (0.30)
SCHEMBL1839886 0.71 ALDH1A1 (0.34)
SCHEMBL28378859 0.67 EGFR (0.34)
SCHEMBL3431866 0.67 TYRO3 (0.40)
Purine SCHEMBL6421376 0.67 KDM4A (0.38)
Purine SCHEMBL2120547 0.67 KDM4A (0.38)
Purine SCHEMBL29456595 0.67
Purine SCHEMBL3157 0.67
SCHEMBL127479 0.67 EGFR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2005 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023136470-A1 PNA MONOMER AND PNA OLIGOMER INCLUDING SAME 주식회사 시선바이오머티리얼스 2023-07-20 WO claimed
US-20230108350-A1 METHOD FOR PRODUCING PNA OLIGOMER IN SOLUTION PROCESS SEASUNBIO MATERIALS (KP) 2023-04-06 US claimed
EP-4083054-A1 METHOD FOR PRODUCING PNA OLIGOMER IN SOLUTION PROCESS Seasunbio Materials (KR) 2022-11-02 EP claimed
CN-114901673-A Method for preparing solution phase peptide nucleic acid oligomer 海阳生物材料有限公司 2022-08-12 CN claimed
CN-111978327-B Preparation method of ticagrelor 南京一心和医药科技有限公司 2022-06-10 CN claimed
WO-2021133033-A1 METHOD FOR PRODUCING PNA OLIGOMER IN SOLUTION PROCESS 주식회사 시선바이오머티리얼스 2021-07-01 WO claimed
WO-2021133032-A1 MODIFIED GAMMA-CARBON SKELETON COMPOUND AND PREPARATION METHOD THEREFOR 주식회사 시선바이오머티리얼스 2021-07-01 WO claimed
US-20210163541-A1 Method for Preparing PNA Oligomer SEASUNBIO MATERIALS (KR) 2021-06-03 US claimed
EP-2179039-B1 RNA SEQUENCE MOTIFS IN THE CONTEXT OF DEFINED INTERNUCLEOTIDE LINKAGES INDUCING SPECIFIC IMMUNE MODULATORY PROFILES ZOETIS BELGIUM S A (BE) 2018-10-31 EP claimed
EP-2516637-B1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS PLASMIA BIOTECH S L (ES) 2016-04-20 EP claimed
EP-0080896-B2 METHOD FOR THE FORMATION OF DYE IMAGE KONICA CORPORATION (JP) 1991-07-24 EP claimed
WO-1991004033-A1 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-04-04 WO claimed
EP-0394346-A1 PYRIMIDINE AND PURINE 1,2-BUTADIENE-4-OLS AS ANTI-RETROVIRAL AGENTS THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1990-10-31 EP claimed
CN-1037148-A Pyrimidine and purine 1-4-alcohol compound as the anti-retroviral agent US HEALTH (US) 1989-11-15 CN claimed
WO-1989006235-A1 PYRIMIDINE AND PURINE 1,2-BUTADIENE-4-OLS AS ANTI-RETROVIRAL AGENTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (US) 1989-07-13 WO claimed
US-4830955-A ANTIFOGGING AGENT KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1989-05-16 US claimed
EP-0244170-A2 Silver halide photographic light-sensitive material and method of processing thereof KONICA CORPORATION (JP) 1987-11-04 EP claimed
EP-0080896-B1 METHOD FOR THE FORMATION OF DYE IMAGE KONICA CORPORATION (JP) 1986-08-13 EP claimed
US-4565774-A SILVER HALIDE EMULSIONS CONTAINING MOSTLY SILVER CHLORIDE; ANTIFOGGING AGENTS; COLOR PHOTOGRAPHY KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1986-01-21 US claimed
EP-0080896-A2 Method for the formation of dye image KONICA CORPORATION (JP) 1983-06-08 EP claimed